Literature DB >> 2249696

Radiolabel-transfer cross-linking demonstrates that protein 4.1 binds to the N-terminal region of beta spectrin and to actin in binary interactions.

P S Becker1, M A Schwartz, J S Morrow, S E Lux.   

Abstract

Erythrocyte protein 4.1 plays a major role in stabilizing the spectrin-actin junction of the erythrocyte membrane skeleton. The particular sites on spectrin responsible for the binding of actin and protein 4.1 have not been specifically defined, although the general region of the 'tail' end, opposite the self-association site, has been deduced by electron microscopy. Using a photoactivatable, radiolabel-transfer cross-linker, 1-[N-(2-hydroxy-5-azidobenzoyl)-2-aminoethyl]-4-(N-hydroxysuccinimidyl)- succinate, we have determined that the binding site for protein 4.1 on spectrin resides in the N-terminal region of beta spectrin within a sequence homologous to the actin-binding region of alpha actinin. Moreover, this technique provided clear evidence for a direct binding interaction between actin filaments and protein 4.1 that was confirmed by rapid-sedimentation assays. In summary, use of radiolabel-transfer cross-linking has enabled assignment of the protein-4.1-binding site on erythrocyte spectrin and has identified a previously ill-defined binary interaction between protein 4.1 and F-actin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249696     DOI: 10.1111/j.1432-1033.1990.tb19406.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Spectrin folding versus unfolding reactions and RBC membrane stiffness.

Authors:  Qiang Zhu; Robert J Asaro
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

2.  An immunocytochemical study of changes in the human erythrocyte membrane skeleton produced by stretching examined by the quick-freezing and deep-etching method.

Authors:  N Terada; Y Fujii; H Ueda; S Ohno
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

3.  Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1.

Authors:  P S Becker; W T Tse; S E Lux; B G Forget
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Cytoskeletal protein binding kinetics at planar phospholipid membranes.

Authors:  A E Mc Kiernan; R I MacDonald; R C MacDonald; D Axelrod
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

5.  Interactions of Plasmodium falciparum erythrocyte membrane protein 3 with the red blood cell membrane skeleton.

Authors:  Karena L Waller; Lisa M Stubberfield; Valentina Dubljevic; Wataru Nunomura; Xuili An; Anthony J Mason; Narla Mohandas; Brian M Cooke; Ross L Coppel
Journal:  Biochim Biophys Acta       Date:  2007-05-10

Review 6.  Refined views of multi-protein complexes in the erythrocyte membrane.

Authors:  T J Mankelow; T J Satchwell; N M Burton
Journal:  Blood Cells Mol Dis       Date:  2012-03-31       Impact factor: 3.039

7.  A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein.

Authors:  S N Mattagajasingh; S C Huang; J S Hartenstein; M Snyder; V T Marchesi; E J Benz
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

8.  Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization.

Authors:  Alejandro Alvarez-Arce; Irene Lee-Rivera; Edith López; Arturo Hernández-Cruz; Ana María López-Colomé
Journal:  Int J Cell Biol       Date:  2017-11-09

9.  Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening.

Authors:  D E Discher; R Winardi; P O Schischmanoff; M Parra; J G Conboy; N Mohandas
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

10.  Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid beta-spectrin.

Authors:  S P Kennedy; S L Warren; B G Forget; J S Morrow
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.